Apricus Biosciences Inc (NASDAQ:APRI)

Data as of Sep 12
 +0.01 / +0.55%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Apricus Biosciences, Inc. is a pharmaceutical company that has developed alternative, fast-acting, treatments which appeal to large patient populations that struggle with sexual performance. The company products include Vitaros and Femprox. It operates through Pharmaceutical segment which designs and develops pharmaceutical products including those with its NexACT platform. Apricus Biosciences was founded in 1987 and is headquartered in San Diego, CA.

Contact Information

Apricus Biosciences, Inc.
11975 El Camino Real
San Diego California 92130
P:(858) 222-8041
Investor Relations:



Individual stakeholders8.47%
Other institutional4.55%
Mutual fund holders4.32%

Top Executives

Richard W. PascoeChief Executive Officer & Director
Steven Robert MartinChief Financial Officer, Secretary & Senior VP
Edward M. CoxVice President-Commercial Development
Neil C. MortonVice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.